https://bills.parliament.uk/bills/3689 A Bill to set a target for the number of glioblastoma patients who take part in clinical trials each year; to require training for medical oncologists to include training relating to brain cancers; to provide that any drug that has been licensed for use on tumours must be trialled on people with brain tumours; to make provision in relation to neuro-oncology multidisciplinary teams in the NHS, including a requirement that each such team must include a medical oncologist; to require manufacturers of drugs licensed to treat tumours to make those drugs available in specified circumstances for clinical trials relating to brain tumours; to make provision about the application of funding caps on funding for multi-drug treatments for glioblastoma brain tumours; to make provision about the processes for funding of drugs intended for the treatment of glioblastoma; to make provision about the management of drug trial data, for the purpose of increasing the quality of data relating to glioblastoma patients; to make provision about reviewing the allocation of existing funding for brain tumour research by the National Institute for Health and Care Research; to make provision about the direct referral of patients by optometrists to accident and emergency departments for the purpose of diagnosing brain tumours; and for connected purposes. Copyright 2026, Houses of Parliament Thu, 18 Jun 2026 08:12:45 +0100 https://bills-api.parliament.uk/Rss/bills/3689 Wed, 28 Feb 2024 00:00:00 GMT https://hansard.parliament.uk/commons/2024-02-28/debates/06FFF455-79DA-4313-B11A-2AFFFA52D940/BrainTumours https://hansard.parliament.uk/commons/2024-02-28/debates/06FFF455-79DA-4313-B11A-2AFFFA52D940/BrainTumours Publication Brain Tumours Bill: 1st reading - Commons Hansard link Thu, 29 Feb 2024 11:31:08 Z 1st reading https://bills.parliament.uk/bills/3689 https://bills.parliament.uk/bills/3689 Sitting Brain Tumours Bill: House of Commons 1st reading Thu, 29 Feb 2024 11:30:25 Z 1st reading